David Krimpa
Chief Business Officer
Replay available
Eton Pharmaceuticals, Inc. (NASDAQ: ETON) Q1 2026 earnings conference call, held 2026-05-14. Replay captured from the company's public earnings webcast.

Chief Business Officer
Chief Executive Officer
Chief Financial Officer
Chief Commercial Officer
Watch the replay and follow the connected company analysis, news, and investor updates for Eton Pharmaceuticals, Inc..
WEBVTT 00:00:00.031 -- 00:00:04.656 Good afternoon, and welcome to the Eaton Pharmaceuticals First Quarter 2026 Financial 00:00:04.656 -- 00:00:10.421 Results Conference Call. At this time, all participants are in listen-only mode. 00:00:10.421 -- 00:00:15.026 Following the formal remarks, we will open the call up for your questions. 00:00:15.026 -- 00:00:18.990 Please revise that this call is being recorded at the company's request. 00:00:18.990 -- 00:00:23.174 At this time, I'd like to turn it over to David Krimpa, Chief Business Officer at Eaton 00:00:23.174 -- 00:00:26.375 Pharmaceuticals. Please proceed. 00:00:28.579 -- 00:00:33.750 Thank you, Operator. Good afternoon, everyone, and welcome to Eaton's first quarter 2026 00:00:33.750 -- 00:00:38.614 conference call. This afternoon, we issued a press release that outlines the topics we 00:00:38.614 -- 00:00:45.238 plan to discuss on today's call. The release is available on our website, eatonfarming.com. 00:00:45.560 -- 00:00:50.685 Joining me on our call today, we have Shondra Jelson, our CEO, James Gruber, our 00:00:50.685 -- 00:00:55.850 CFO, Judy Matthews, our Executive Vice President of Finance, and Ipek 00:00:55.850 -- 00:01:00.873 Trinkaus, our Chief Commercial Officer. In addition to taking live questions 00:01:00.873 -- 00:01:05.460 on today's call, we will also be answering questions that are emailed to us. 00:01:05.460 -- 00:01:10.565 Investors can send their questions to investorrelations at eatonfarmer.com. 00:01:10.769 -- 00:01:15.697 Before we begin, I would like to remind everyone that remarks made during the call may 00:01:15.697 -- 00:01:20.565 contain forward-looking statements that involve risks and uncertainties that could cause 00:01:20.565 -- 00:01:25.975 actual results to differ materially ...